Article
Complexities of Next-Generation Sequencing in Solid Tumors: Case Studies.
Journal of the National Comprehensive Cancer Network : JNCCN - 1 Sept 2020
Sokolova Alexandra O, Shirts Brian H, Konnick Eric Q, Tsai Ginger J, Goulart Bernardo H L, Montgomery Bruce, Pritchard Colin C, Yu Evan Y, Cheng Heather H
Abstract excerpt
With the promise and potential of clinical next-generation sequencing for tumor and germline testing to impact treatment and outcomes of patients with cancer, there are also risks of oversimplification, misinterpretation, and missed opportunities. These issues risk limiting clinical benefit and, at worst, perpetuating false conclusions that could lead to inappropriate treatment selection, avoidable toxicity, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
